DSS Takara Bio India Pvt. Ltd.

DSS Takara Bio India Pvt. Ltd. is a joint venture between DSS Imagetech Pvt. Ltd. and Takara Bio Inc., established in 2011 with the aim of manufacturing and marketing Takara Bio research kits and reagents in India, in order to more adequately address the needs of the local scientific community.

DSS Imagetech Pvt. Ltd. (formerly known as Darbara Singh & Sons) has been serving the Indian life sciences research fraternity for more than 50 years as a supplier of equipment and consumables from world-renowned companies from around the globe and has been representing Takara Bio Inc. in India since 2005.

Our corporate office and manufacturing facility are both located in New Delhi, and we have a presence in 9 major cities in India (Delhi, Chandigarh, Kolkata, Mumbai, Pune, Hyderabad, Chennai, Bangalore, Trivandrum), with sales representatives situated in several other locations. Our highly qualified team includes a dedicated salesforce, applications specialists with extensive scientific expertise, a capable logistics group that is well-versed in handling both instruments and consumables, and our partners in Japan, who provide invaluable technological know-how.

The formation of DSS Takara Bio India Pvt. Ltd. was made possible through your support, and going forward we will continue to provide the Takara, Clontech, and Cellartis-branded products you have come to rely on for your research, in addition to comprehensive product lines from world-class partners such as Macherey-Nagel and Promocell. At DSS Takara Bio India Pvt. Ltd., customer success will always be our primary objective.

Click here to know more about the products and services offered by DSS Takara Bio India (DTI)

Upcoming WorkShops/Webinars

Webinar : PicoPLEX Chemistry from Takara Bio for Reproductive Health Applications

                                                                          Register here 

Advances in Preimplantation genetic testing techniques and technologies have made a real difference in increasing the chances of pregnancy and reducing the risk of miscarriage and congenital disabilities due to genetic disorders. Preimplantation genetic testing (PGT) is performed to screen embryos for chromosomal abnormalities (PGT for aneuploidy [PGT-A]) or known/suspected genetic conditions (PGT for monogenic diseases [PGT-M]).

NGS-based Preimplantation genetic testing allows the determination of whether an embryo is euploid, aneuploid, mosaic, and/or carrying single-gene mutations. But we often get limited number of cells or genetic material from the embryos to perform the detection of both aneuploidy and monogenic diseases with accuracy.

To overcome this challenge Takara Bio have developed PicoPLEX technology which is designed and optimized for unbiased amplification of single-copy genomic DNA from inputs as low as a single cell or cell-free DNA from liquid biopsies and generate high-quality DNA libraries. The simple protocol reduces handling errors, dramatically improves time to results, and reduces background. It is trusted as the gold-standard DNA amplification technology for PGT due to its accuracy and reproducibility.

In this Webinar you will discover

• Highly reproducible and accurate single cell whole-genome amplification from single cells or lesser input of DNA using PicoPLEX technology
• Simultaneous detection of SNPs and CNV for PGT-M and PGT-A using a single-tube next generation sequencing assay.